Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.81M | -26.53M | -28.36M | -29.97M | -31.45M |
| Total Depreciation and Amortization | 1.69M | 2.37M | 3.06M | 2.57M | 2.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.07M | 798.90K | -1.40M | 4.10M | 9.68M |
| Change in Net Operating Assets | -3.77M | 458.30K | 4.64M | 4.64M | 4.64M |
| Cash from Operations | -23.83M | -22.90M | -22.06M | -18.65M | -15.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.20M | 1.49M | 1.77M | 793.70K | -210.60K |
| Cash from Investing | 1.20M | 1.49M | 1.77M | 793.70K | -210.60K |
| Total Debt Issued | -- | 2.20M | 4.40M | 5.89M | 7.37M |
| Total Debt Repaid | -1.90M | -3.00M | -4.10M | -4.63M | -5.17M |
| Issuance of Common Stock | 53.98M | 63.68M | 73.37M | 51.51M | 29.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.65M | -7.75M | -8.85M | -5.25M | -1.65M |
| Cash from Financing | 29.79M | 36.26M | 42.77M | 31.49M | 19.87M |
| Foreign Exchange rate Adjustments | 3.30K | 154.80K | 303.00K | 145.50K | -16.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.16M | 15.00M | 22.79M | 13.77M | 4.58M |